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Abstract Objective:Pleural fluidparameters that predict a diagnostic closedpleuralneedle biopsy were investigated.
Design: Aretrospective analysis.
Setting:The Institute of Pulmonology,Hadassah University Hospital.
Patients and methods: Forty-four patients who underwent closed pleural needle biopsies were included in this study.
Pleural fluidvalues of protein, glucose, lactate dehydrogenase (LDH), pH, andwhite blood cell countwith differential cell
counts, frompatientswith diagnostic andnon-diagnostic pleural biopsieswere compared.
Results:Thirteenpatients (29%) had diagnostic biopsies.Malignancy was identified in10 patients (23%), of whom 70%
had adenocarcinoma.Three otherpatientshadnon-malignant specificdiagnosis.LDHlevels inpleural fluid frompatients
with diagnostic pleural biopsy were higher than in patients with non-diagnostic pleural biopsies (14367333Ul1 vs.
7757109Ul1; Po0.05).LDH levels less than 510Ul1were highly predictive of a negative biopsy (negative predictive
value of 86.6%). Follow up revealed malignancy including mesothelioma and lymphoma, in10 of 30 (33%) patients with
non-diagnostic biopsies, and one patient died of unrelated cause, while the pleural effusion either resolved, remained
stable or an alternative benignprocesswas identified in19 patients (63%).
Conclusions:Lowlevels of LDH (o510Ul1) werehighlypredictive of a negative pleuralneedle biopsy.Thus,LDHmay
serve as a useful guide in deciding whether to perform closed pleural biopsy or to proceed to thoracoscopically guided
biopsy.r2002 Elsevier Science Ltd.Allrights reserved.
Available online athttp://www.sciencedirect.com
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In adultswith a newlydetectedexudativepleural e¡usion
and no evidence of an acute infectious process (para-
pneumonic e¡usion), exclusion ofmalignancy or tubercu-
lous pleurisy becomes a priority, especially, if there is
lymphocyte predominance in the pleural £uid (1). If initial
cytologic and microbiologic studies of the pleural £uid
are notdiagnostic, a pleural biopsy shouldbeperformed.
Closedpleuralneedlebiopsy is a simplebedsideproce-
dure which can be performed on an ambulatory basis,
has a high diagnostic yield for the detection of malig-
nancy and tuberculosis, and has a low rate of complica-
tions in experienced hands. Thoracoscopy and the
recently developed video-assisted thoracoscopic sur-
gery are attractive alternative diagnostic methods that
are minimally invasive with high diagnostic yield. OpenReceived 20 August 2001, accepted in revised form 20 March 2002.
Correspondence should be addressed to:Dr Samir Nusair,MD,
Institute of Pulmonology,HadassahUniversity Hospital, P.O.Box12072,
Jerusalem 91120, Israel. Fax: +972-2-6435897;
E-mail: samjack@shani.netsurgical procedures such as thoracotomy with pleural
biopsy has the highest diagnostic yield. The advent of
minimally invasive thoracoscopy has led us to review
our experiencewith closed pleural biopsy, in an attempt
to identify pleural £uidparameters thatmaypredict a di-
agnostic closed pleural biopsy, thereby allowing better
selection of which patients should proceed directly to
thoracoscopy-guided pleural biopsy.
METHODS
We performed a retrospective analysis of the medical
charts of 44 adult patients, who underwent closed
pleural needlebiopsies at theHadassahUniversity hospi-
tal, during the timeperiod fromMay1993 untilMay 2000.
In our institution, closed pleural biopsy is performed in
patients with an exudative pleural e¡usion with no ac-
companyingpleural or subpleural thickeningormass that
can be sampled using imaging-guided needle biopsy
(ultrasonography or computerized tomography), and in
FIG. 1. Biopsy ¢ndings in 44 closedpleuralbiopsies.
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is negative.
Pleural £uid from all patients was examined for pH,
glucose, total protein, and lactate dehydrogenase (LDH)
levels. White blood cell counts with di¡erential counts
were determined using an automated coulter. Cytologic
examination of the £uid was performed on centrifuged
concentrateusing Papanicolaou stain.Fluid samples were
routinely stainedbyGram andZiehl^Neelsen stains and
sent for bacterial, fungal andmycobacterial cultures.The
pleural £uid was classi¢ed as an exudate according to
Light’s criteria requiring one of the following: (1) £uid
protein/blood protein ratio 40.5; (2) £uid LDH/blood
LDH ratio 40.6; (3) £uid LDH greater than 2/3 of the
maximal normal serum LDH levels (normal range is
300^620Ul1 in our institution).
Pleural biopsies were obtained at the bedside using
Abrams needle using standard technique (2). A pleural
biopsy is considered adequate if at least three specimens
containing pleural tissuewere obtained.
Specimenswereprocessed and sectioned at 5mm, and
stained routinely with hematoxylin and eosin; and when
appropriate, Ziehl^Neelsen or special immunohisto-
chemical stains.Pleural tissuewas also submitted formy-
cobacteria and fungal cultures.
In cases where the pleural biopsy revealed only me-
sothelial tissuewith varying degrees of acute and chronic
in£ammation, thebiopsy was interpreted as non-speci¢c
pleuritis.Outcome of patients with such non-diagnostic
pleural biopsies was determinedby reviewing theirmed-
ical records, and contactingpatients and their physicians.
When therewas no speci¢c diagnosis (malignancy or tu-
berculosis), an attempt was made to establish whether
the pleural e¡usion had changed or resolved over time.
Statistical evaluation was performed using unpaired t-
test to compare between groups, and a two-tailed P va-
lueo0.05 was considered statistically signi¢cant.
RESULTS
Forty-four adult patients (average age 65 years, range
24^88 years) who underwent closed pleural needle
biopsy were identi¢ed. All patients had adequate speci-
mens. All patients had exudative pleural e¡usion accord-
ing to Light’s criteria. The pleural e¡usion occupied at
least 25% of the ipsilateral pleural space as estimated on
posteroanterior chest X-ray ¢lm, and no accompanying
pleural masses were identi¢ed. All patients had at least
one previous negative cytologic examination of the
pleural £uid, 31% had two negative examinations and
10% had three ormore negative cytologic examinations.
Of 44 patients, closed pleural biopsy yielded a diagno-
sis in 29% (13/44) cases.Of these, a malignancy was de-
tected in10 patients (23%) (Fig.1). In one patient, biopsy
revealed the presence of tuberculous pleurisy, with acaseating granuloma and positive culture. One patient
had sarcoidosis and another extramedullary hematopo-
esis. Thirty-one patients (71%) had ¢ndings of acute or
chronic pleuritis with variable degrees of mesothelial
atypia, and thus were classi¢ed as non-speci¢c pleuritis.
Of the patients in whom a malignancy was identi¢ed
on pleural biopsy, 70% (7/10) had adenocarcinoma. Two
patients had metastatic malignant pleural e¡usion
(breast carcinoma, papillary carcinoma of thyroid).
One patient had bronchogenic squamous cell carcinoma,
and the other poorly di¡erentiated non-small cell
carcinoma.
The major purpose of this study was to determine
whether pleural e¡usion parameters predict a positive
diagnostic yield from a closed pleural needle biopsy. Bio-
chemical and cellular values in thepleural £uid ofpatients
with diagnostic and non-diagnostic pleural biopsies are
presented in Table 1. Although glucose and pH values
were lower in the pleural £uid from patients with a diag-
nostic pleural needle biopsy, and protein and LDH levels
were higher, only raised LDH values (14367333Ul1 vs
7757109Ul1;Po0.05) signi¢cantlypredicted a diagnos-
tic pleural biopsy (Table 1). Individual values of pleural
£uid LDH available from 40 patients are presented in
Fig. 2.Using absolute cuto¡ value of 510Ul1, LDHvalues
greater than 510 were found in11out of13 cases with di-
agnostic biopsies. This cuto¡ value gives a sensitivity of
84.6%, speci¢city of 48.1%, positive predictive value of
44%, and a negative predictive value of 86.6% (Table 2).
Notably, therewas no signi¢cant di¡erence in the per-
centage of lymphocytes in the pleural £uid frompatients
with diagnostic pleural biopsies, compared to £uid ob-
tained frompatients with non-diagnostic biopsies.
Complications of pleural biopsy included vasovagal
syncpoe (2 patients), and subcutaneous hematoma
(1 patient). There were no cases of pneumothorax or
hemothorax as a result of the procedure.
TABLE 1. Pleural £uidparameterspredicting yield of closedneedle pleuralbiopsy.Results are presented inmean7SEM
Diagnostic biopsy Non-diagnostic biopsy Statistical signi¢cance
Glucose (mmoll1) 5.1170.96 (n=12) 7.0470.63 (n=30) NS
LDH (U) 14367333 (n=13) 7757109 (n=27) Po0.05
Protein (gl1) 4573 (n=14) 4272 (n=29) NS
pH 7.4870.10 (n=10) 7.6270.04 (n=19) NS
Lymphocytes in £uid (%) 6079 (n=11) 6375 (n=24) NS
FIG. 2. Individual LDH values in the pleural £uid of diagnostic
and non-diagnostic pleural biopsies.Dashed horizontal line indi-
cates a cuto¡ value of 510Ul1.
TABLE 2. Predictive power of pleural £uid LDH levels
higher than 510Ul1 in anticipating a diagnostic (malig-
nant or granulomatous) (n = 13), and non-diagnostic
(n = 28) pleuralbiopsies
True-positives 11
True-negatives 13
False-positives 14
False-negatives 2
Sensitivity, % 84.6
Speci¢city, % 48.1
Positive predictive value 44
Negative predictive value 86.6
FIG. 3. Outcome of 30 patients with non-diagnostic closed
pleuralneedle biopsy, inwhom follow up could be obtained (fol-
lowup: median 39 months, range 2^87 months).
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patientswith non-diagnostic closedpleuralbiopsy, with a
median follow up time interval after biopsy of 39months
(range from 2 to 87 months). A malignancy was even-
tually diagnosed in 10/30 (33%) of these patients (Fig. 3).
Two patients had mesothelioma diagnosed by thoraco-
scopy, and two patients had lymphoma. In one patient,lymphoma was diagnosed based on ¢ndings in axillary
lymph node biopsy, and in the other recurrence of lym-
phomawas detected by a transbronchial biopsy from an
accompanying pulmonary in¢ltrate. The other six pa-
tients had carcinoma, primary or secondary.
In19 patients (63%) with a negative pleural biopsy, the
pleural e¡usion either resolved, stayed stable or an alter-
nativebenignprocess (hypothyroidism and idiopathic eo-
sinophilic pleuritis) was identi¢ed. One further patient
diedofnon-relatedcauses.From these data,weconclude
that closed pleural biopsy has an overall diagnostic sensi-
tivity formalignancy of 50% (62.5% for adenocarcinoma),
and a speci¢city of100%.
DISCUSSION
Patients with a diagnostic pleural biopsy had lower glu-
cose levels and pH, and higher LDH and protein levels as
compared with patients with non-diagnostic biopsies.
However, only LDHlevelswere signi¢cantlydi¡erentbe-
tween the two groups. In patients with an LDH of less
than 510Ul1, a closed pleural biopsy is highly unlikely to
PLEURALBIOPSYANDFLUIDLDH 893be diagnostic (negative predictive value of 86.6%). LDH
levels greater than 510Ul1predict a positive diagnostic
pleural needle biopsy in 44% of cases.
Pleural biopsy is recommended for patients with an
undiagnosed exudative pleural e¡usion, especially if
there is lymphocytic predominance in the pleural £uid
(1). Although thoracoscopy-guidedbiopsyhas a high diag-
nostic yield for both benign and malignant disease (95%
for malignancy and 99% for TB) (3,4), in most patients,
blind closed pleural needle biopsy remains a valid initial
diagnostic option.
Pleural needle biopsy yielded a speci¢c diagnosis in
29% of our patients. Previous studies show that pleural
needle biopsy yields a speci¢c diagnosis in one-third to
one-half of patients, with about 80% of the diagnostic
biopsies demonstrating malignancy, while tuberculosis is
the secondmost common ¢nding (5,6).
In our study, the diagnostic yield of pleural needle
biopsy for detection of malignancy was 23%. This is
somewhat lower than the yield found in most reports
which ranges from 27^56% (7^9). Previous studies have
shown a relatively higher yield for the detection ofmalig-
nant cells within the pleural £uid than from pleural
biopsy from patients with malignant pleural e¡usion
(7,10). However, the combined diagnostic yield of pleural
£uid cytology and pleural biopsy was the highest (58%
for £uid examination, 43% for pleural needle biopsy and
64% for both procedures combined) (10).
In most of our patients who had a malignant pleural
e¡usion, the underlying histology was adenocarcinoma,
similar to previous reports (5,10).Other malignant pro-
cesses thatmay involve the pleura such asmesothelioma
and lymphoma are di⁄cult to diagnose by histologic ex-
amination of closed needle biopsy material, and pleuro-
scopy or thoracoscopy may be preferred when these
conditions are suspected.
The combination of pleural £uid andpleural biopsy ex-
amination with culture of specimens from these two
procedures, is considered a highly sensitive diagnostic
method for the detection of tuberculous pleural e¡usion
(11). Only one patient in our series, had a pleural biopsy
positive forTB,with no falsenegativebiopsies.This prob-
ably re£ects the low incidence of TB in our geographic
area.
The major purpose of this study was to determine
whether pleural £uid parameters could predict a diag-
nostic pleural needle biopsy. Glucose levels and pH of
the pleural £uid are known to be lower in patients with
a malignant e¡usion in whom there is a large metabolic
burden of tumor cells. Although patients with a diagnos-
tic pleural biopsy tended to have higher LDHandprotein
levels and lower glucose levels and pH as comparedwith
patients with non-diagnostic biopsies, only LDH levels
were signi¢cantly di¡erent between the two groups. All
but twopatientswith a positivebiopsy had an LDHvalue
of greater than 510Ul1 (Fig. 2). The sensitivity and thespeci¢city for this LDH cuto¡ value were 84.6 and
48.1%, respectively.The practical value of LDHmeasure-
ment in predicting outcome of biopsies lies in the high
negative predictive value of this test (86.6%); thus, in pa-
tients with an LDH of less than 510Ul1, a closed pleural
biopsy is highly unlikely to be diagnostic. LDH levels
greater than 510Ul1predict a positive diagnostic pleur-
al needle biopsy in 44% of cases.This value is signi¢cantly
higher than the percentage of total positive biopsies
(29%) in our patients. An LDH level greater than
510Ul1 in undiagnosed exudative pleural e¡usion is
more predictive of a positive closed biopsy than is the
presence of lymphocyte predominance. On the other
hand, LDH levels lower than 510Ul1suggest that pleur-
al needle biopsy is less likely to yield a diagnosis, and one
should proceed directly to thoracoscopically guided
biopsy, whenever a malignancy is strongly suspected.
Our ¢ndings are consistent with previously described
studies in which higher LDH levels predicted greater ac-
tivity of pleural disease, such as greater residual pleural
thickening after pleural TB (12), and more prominent
pleural thickening on chest CT as a result of infectious
or malignant processes (13). In the study of Harris et al.,
patients who underwent pleuroscopic pleural biopsy
had a positive diagnostic yield thatcorrelatedwithhigher
preoperative LDH levels in the pleural £uid (14). From
our data, we also conclude that lymphocytosis in the
pleural £uid was not helpful in predicting a diagnostic
pleural biopsy.
Follow up of our patientswith non-diagnostic biopsies
extending over amedian interval of 39months (range 2 ^
87months) revealed thatonly 33%of thesepatientswere
eventually found to have a malignant process.Therefore,
after excluding three patients in whom follow up could
not be obtained, the sensitivity of closed pleural biopsy
for diagnosingmalignancy using Abrams needle was 50%
(62.5% for adenocarcinoma) in our series, with a speci¢-
city of100%, and a negative predictive value of 67.7%.
The outcome of patients with non-speci¢c pleuritis
was generally favorable with lowmorbidity and mortal-
ity, similar to previously published data (6,15). In patients
who were initially diagnosed as non-speci¢c pleuritis,
malignancy was eventually found in 20^30%, and an-
other 5% of the patients had TB. Sixty to 80% of the pa-
tients had a benign clinical coursewith gradual resolution
of the £uid or the ¢nding of an alternative non-malignant
process.
CONCLUSIONS
In the presence of undiagnosed pleural e¡usion, closed
needle pleural biopsy is diagnostic in one-third of pa-
tients, in whom most cases are malignancy, and speci¢-
cally adenocarcinoma.Thirty percent of negative pleural
biopsies will later prove to be malignancy related;
894 RESPIRATORYMEDICINEhowever, most of the patients with negative closed nee-
dle pleural biopsy will have a favorable outcome. Our
data show that pleural £uid LDH less than 510Ul1 is
highly predictive of a negative closed pleural biopsy. In
contrast, pleural £uid LDH greater than 510Ul1 may
be a better predictor of positive yield of closed pleural
biopsy, than the currently used criteria.
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